Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer.

Purpose: Though less than 5% of patients with breast cancer present with De Novo Metastasis (dnMBC) in Western societies, this percentage may reach 30% in developing countries. In this study, we present survival outcomes of patients diagnosed with dnMBC treated at a tertiary center in a developing country.

Patients And Methods: Using hospital-based database, consecutive patients with dnMBC diagnosed between 2013 and 2017 were identified.